Opioid-use Disorder Clinical Trials

24 recruiting

Frequently Asked Questions

Common questions about Opioid-use Disorder clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 24 trials

Recruiting
Phase 2

MDMA for Co-occurring PTSD and OUD After Childbirth

Stress Disorders, Post-TraumaticOpioid-use Disorder
University of New Mexico15 enrolled1 locationNCT05219175
Recruiting
Phase 2

Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder

Opioid-use DisorderOpioid Use Disorder, ModerateOpioid Use Disorder, Severe
T. John Winhusen, PhD310 enrolled10 locationsNCT06651177
Recruiting
Not Applicable

HIV, Equity, and Addiction Training (HEAT) Program

Substance Use DisordersOpioid-use DisorderHIV+1 more
University of Alabama at Birmingham30 enrolled1 locationNCT06370481
Recruiting
Not Applicable

Open Pilot Trial of Adapted Cognitive Processing Therapy for Comorbid PTSD and Opioid Use Disorder

Opioid-use DisorderPosttraumatic Stress Disorder (PTSD)
The City College of New York15 enrolled1 locationNCT06872164
Recruiting
Not Applicable

Integrated Treatment for Opioid Use Disorder and PTSD

Opioid-use DisorderPosttraumatic Stress Disorder (PTSD)
Medical University of South Carolina76 enrolled1 locationNCT06641115
Recruiting
Not Applicable

Technology-Enhanced Therapy vs. Medication Monitoring for Buprenorphine Retention in Pregnant Persons

PregnancyOpioid-use Disorder
Medical University of South Carolina37 enrolled1 locationNCT06999811
Recruiting
Not Applicable

Low-Intensity Focused Ultrasound and the Complex Patient

Chronic PainOpioid-use DisorderAnxiety Disorder
Virginia Polytechnic Institute and State University25 enrolled1 locationNCT06297200
Recruiting
Not Applicable

Expanding Medication-Assisted Therapies in Central Asia

Opioid-use Disorder
Yale University900 enrolled4 locationsNCT05579470
Recruiting

Infectious Disease (ID) Testing OUtreach in Carceral Hubs

HIV InfectionsOpioid-use Disorder
Boston Medical Center75 enrolled1 locationNCT06679751
Recruiting
Not Applicable

Project I Test: Implementing HIV Testing in Opioid Treatment Programs

Substance Use DisordersOpioid-use DisorderHepatitis C+1 more
Columbia University418 enrolled1 locationNCT03135886
Recruiting
Not Applicable

Community-based Education, Navigation, and Support Intervention for Military Veterans

HIV InfectionsOpioid-use DisorderOverdose
New York University300 enrolled1 locationNCT05343169
Recruiting
Not Applicable

Promoting HIV Risk Reduction Among People Who Inject Drugs: A Stepped Care Approach Using Contingency Management With PrEP Adherence and Support Services

Opioid-use DisorderHIV Prevention Program
Yale University526 enrolled6 locationsNCT04738825
Recruiting
Phase 2

Lofexidine Combined With Buprenorphine for Reducing Symptoms of PTSD and OU Relapse in Veterans

Post Traumatic Stress DisorderOpioid-use Disorder
Pharmacotherapies for Alcohol and Substance Use Disorders Alliance120 enrolled2 locationsNCT04360681
Recruiting
Phase 4

Integrated e-Health (Electronic Health) for HIV and Substance Use Disorders in Justice Involved Women

Opioid-use DisorderHIVeHealth
Yale University250 enrolled2 locationsNCT05547048
Recruiting
Not Applicable

PrEP and MOUD Rapid Access for Persons Who Inject Drugs: The CHORUS+ Study

Opioid-use Disorder
Boston Medical Center284 enrolled2 locationsNCT05769218
Recruiting
Not Applicable

Novel Telemedicine-Delivered Prolonged Exposure Therapy for Treating PTSD in Individuals With OUD

Opioid-use DisorderPosttraumatic Stress Disorder
University of Vermont135 enrolled1 locationNCT06288711
Recruiting

Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Healthy ControlSchizophreniaPost Traumatic Stress Disorder+4 more
Yale University100 enrolled1 locationNCT01730781
Recruiting
Phase 4

Optimizing Evidence-based HIV Prevention Targeting People Who Inject Drugs on PrEP

Opioid-use DisorderHIV
University of Connecticut256 enrolled1 locationNCT05669534
Recruiting
Not Applicable

Randomized Trial of ACT and a Care Management App in Primary Care-based Buprenorphine Treatment

Chronic PainOpioid-use Disorder
Albert Einstein College of Medicine160 enrolled1 locationNCT05039554
Recruiting

Computer Game, Qualitative, and MEG/EEG Assessment of Serotonergic Psychedelics

Healthy VolunteerTobacco Use DisorderMigraine+8 more
Yale University200 enrolled2 locationsNCT06624137